1. Teva Pharmaceutical won FDA approval for Ajovy, an injection given to patients every few months to relieve migraines.
2. PK Papyrus Covered Coronary Stent System is a medical device for the treatment of acute coronary artery perforations, or tears in the blood vessels of the heart.
3. Avita Medical received approval for its Recell Autologous Cell Harvesting Device for the treatment of severe thermal burns in patients 18 years or older.
4. Xelpros, a drug manufactured by Sun Pharma, was approved to reduce open angle glaucoma or ocular hypertension.
More articles on supply:
Amazon, Merck, Accenture to launch data-driven drug development platform
UCHealth urges blood donations after hitting critically low supply
FDA scolds pharmaceutical lab for operating microbrewery in drug testing space
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
